S.H.N. Financial Investments Ltd. - Mar 4, 2025 SCHEDULE 13G Report for Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV)

Filing Manager: S.H.N. Financial Investments Ltd.
Reporting Manager: S.H.N. Financial Investments Ltd.
Security: Plus Therapeutics, Inc. Common Stock, $0.001 par value
Symbol: PSTV
Shares outstanding: 12.1M shares
Disclosed Ownership: 1.21M shares
Ownership: 9.99%
Form type: SCHEDULE 13G
Date filed: 3/18/2025, 04:17 PM
Date of event: Mar 4, 2025
Next filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
S.H.N. Financial Investments Ltd.	9.99%	1.21M	1.21M	0	/s/ Nir Shamir	Nir Shamir, Chief Executive Officer